Announcements
- Shareholders IMCD N.V. adopt all resolutions at AGM
- IMCD reports EBITA of EUR 127 million in the first three months of 2024
- IMCD Spain expands its Pharmaceuticals presence with the acquisition of Cobapharma
- IMCD publishes convocation for its upcoming Annual General Meeting
- IMCD Benelux expands its Beauty & Personal Care presence with the acquisition of Gova Ingredients
- IMCD further expands its food and nutrition footprint in Latin America with the acquisition of Bretano
- IMCD announces dividend proposal and Supervisory Board nominations for reappointment
- IMCD reports EBITA of EUR 515 million in 2023
- IMCD Australia and New Zealand strengthen its coatings and construction business with the acquisition of ResChem
- IMCD completes acquisition of remaining 30% of Signet Excipients Private Limited
More ▼
Key statistics
As of last trade IMCD NV (INX:FRA) traded at 138.15, -16.32% below its 52-week high of 165.10, set on Mar 25, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 138.15 |
---|---|
High | 138.15 |
Low | 138.15 |
Bid | 139.35 |
Offer | 142.10 |
Previous close | 137.05 |
Average volume | 5.11 |
---|---|
Shares outstanding | 56.99m |
Free float | 55.99m |
P/E (TTM) | 27.31 |
Market cap | 7.99bn EUR |
EPS (TTM) | 5.13 EUR |
Annual div (ADY) | 2.24 EUR |
---|---|
Annual div yield (ADY) | 1.63% |
Div ex-date | May 16 2024 |
Div pay-date | May 21 2024 |
Data delayed at least 15 minutes, as of May 24 2024 07:02 BST.
More ▼